abstract |
[Chemical 1] Disclosed are compounds of formula (I) that are bradykinin B1 receptor (B1R) antagonists. These compounds are useful for the treatment of diseases associated with inflammation and pain or for alleviating adverse symptoms. The present invention includes novel compounds and acceptable derivatives thereof, pharmaceutical compositions and methods for the prevention and treatment of diseases including inflammation and pain. |